[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Facial Injectables Market Report: 2013 Edition

September 2013 | 65 pages | ID: G41A9670DBCEN
Koncept Analytics

US$ 800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Cosmetic surgery is an exclusive branch of medical science that focuses on enhancing appearance of an individual through surgical and medical procedures; while preserving their unique attributes. On the other hand, plastic surgery is defined as a surgical specialty that focuses on repairing and reconstructing the abnormal structures of the body parts. Cosmetic procedures include surgical procedures as well as non-surgical procedures. Both surgical and non-surgical procedures are considered to be an appropriate treatment for the people who want to inculcate an instant change in their appearance. However, along with the various advantages, aesthetic surgical procedures also have certain disadvantages associated with them.

Minimally invasive and non-invasive procedures; also know as petit surgery have become mainstream in cosmetic surgery industry. Around 20 years ago, facelift surgery was the only way to get rid of wrinkles but presently facial injectables are the most widely used treatment for the same. Over the past few years, the popularity of facial injectables has grown considerably well and this change can be attributed to their convenience and relatively low cost. Facial injectables are broadly divided into three categories, namely botulinum toxin, traditional fillers; also know as dermal fillers; and collagen stimulators. Out of the aforementioned procedures, the global facial injectables market is majorly governed by two segments namely, botulinum toxin and dermal filler injectables. Apart from the application in facial injectables, botulinum toxin is also used for ophthalmology, dentistry, gastroenterology, plastic surgery, Urology purposes. Common applications of the dermal filler treatment are lip augmentation, cheek plump, reduction of marionette lines.

In most of the western countries, a strong growth in the demand for facial injectables has been observed among males and females aged 40 to 54. This increase was noted on the account of rise in demand for the anti-aging treatments. In today’s modern arena of technological innovation, one of the most effective non-surgical procedures is Radio Frequency facials. The US Food and Drug Administration (FDA) has approved radio frequency facelifts as a non-surgical treatment for wrinkles and facial skin imperfections. Managing unrealistic expectations of the clients remains one of the major challenges faced by this industry. Moreover, lack of proper regulations on cosmetic intervention by unauthorized practitioners is a matter of concern for global aesthetics industry.

With the focus on research and development activity, expansion in the global marketplace and invention of new products, the key players of botulinum toxin include Allergan, Ipsen and Merz, apart from other players. Some of the major players of dermal filler market are Galderma, Bloomage BioTechnology and Beijing Emeical BioTechnology.

This report provides an analysis of the global facial injectables market. It discusses major challenges faced by the industry along with major market tends and industry developments. The report also includes the competitive structure of the industry, regional analysis and profiles of major players with a discussion of their key business strategies.
1. OVERVIEW OF AESTHETIC/COSMETIC PROCEDURES AND PLASTIC SURGERY

1.1 Cosmetic Procedures
  1.1.1 Cosmetic Surgical Procedure
  1.1.2. Cosmetic Non-Surgical Procedures
1.2. Plastic Surgery

2. GLOBAL AESTHETIC INDUSTRY

2.1 Aesthetic Procedures Market Value
  2.1.1 Market by Region
    Market Value
    Growth Rate
  2.1.2 Market by Segments
    Growth Rate
2.2 Aesthetic Procedures Market Volume
  2.2.1 Global Aesthetic Surgical Market
    Major Countries by Procedures
    Market Segmentation
  2.2.2 The US Aesthetic Surgical Market
    Total Procedures
    Market Segmentation
  2.2.3. Global Aesthetic Non-Surgical Market
    Major Countries by Procedures
    Market Segmentation
  2.2.4 The US Aesthetic Non-Surgical Market
    Total Procedures
    Market Segmentation

3. FACIAL INJECTABLES

3.1 Introduction
3.2. Global Facial Injectables Market
  Market Value
  Market Segmentation
3.3. Bi-Segment Distribution of Facial Injectables Market
  3.3.1. Botulinum Toxin
    Major Applications
    Price Structure
    Market Value
    Regional Breakdown
  3.3.2. Dermal Fillers
    Classification of Dermal Fillers
    Price Structure
    Market Value
    Regional Breakdown

4. FACIAL INJECTABLES - REGIONAL ANALYSIS

4.1 The US
  4.1.1. Botulinum Toxin Type A Market
    Market Value
    Market Volume
    Gender - wise Distribution
  4.1.2. Hyaluronic Acid Filler Market
    Market Value
    Market Volume
    Gender-wise Distribution
4.2. China
  4.2.1. Hyaluronic Acid Market
    Market Volume
4.3 Korea
  4.3.1 Botulinum Toxin Market
    Market Value

5. MARKET DYNAMICS

5.1 Trends, Developments and Growth Drivers
  5.1.1 Decrease in Facelifts Surgical Procedures
  5.1.2 Growing Market Potential among Mid Aged People
  5.1.3. Technological Innovations
5.2 Challenges
  5.2.1 Lack of Treatment for Lower Face
  5.2.2 Managing Customer Expectations
  5.2.3 Inadequate Regulations in the Industry

6. COMPETITIVE LANDSCAPE

6.1. Global Market Share by Segment
  6.1.1 Botulinum Toxin
    Market Share
    Product Comparison
  6.1.2 Hyaluronic Acid Filler Market
    Market Share
6.2 Regional Market Share
  6.2.1 China
    Market Share
    Product Comparison
    Penetration Rate
  6.2.2 Korea
    Market Share
    Product Comparison

7. COMPANY PROFILES

7.1 Allergan Inc.
  7.1.1 Business Overview
  7.1.2 Financial Overview
  7.1.3 Business Strategies
    Business Expansion through Acquisitions
    Focus on Research & Development
7.2 Merz Pharma GmbH & Co. KGaA
  7.2.1 Business Overview
  7.2.2 Financial Overview
  7.2.3 Business Strategies
    Continuous Launch of New Products
    Global Presence via Distribution Partners
7.3 Ipsen
  7.3.1 Business Overview
  7.3.2 Financial Overview
  7.3.3 Business Strategies
    Planned Investment Target
    Global Expansion

LIST OF CHARTS

Revenues of Aesthetics Procedure Market by Region (2011)
Percentage Share in Revenue of Worldwide Aesthetics Procedure Market (2011)
Region-Wise Growth Rate of Aesthetic Market (2012-2013E)
Growth Rate of Aesthetic Market Segments (2012-2013E)
Segment-Wise Distribution of Total Aesthetic Surgical Procedures (2011)
Number of Aesthetic Surgical Procedures in the US (2000, 2011-2012)
Segment-Wise Percentage Distribution of US Aesthetic Surgical Procedures (2012)
Segment-Wise Distribution of Total Aesthetic Non-Surgical Procedures (2011)
Number of Aesthetic Non-Surgical Procedures in The US (2010, 2011-2012)
Segment-Wise Percentage Distribution of US Aesthetic Non-Surgical Procedures (2012)
Global Facial Injectables Market (2010-112)
Segment- Wise Distribution of Global Facial Injectable Market (2012)
Percentage Distribution of Segments of the Global Facial Injectable Market (2012)
Global Botulinum Toxin Market (2010-2012)
Region-Wise Distribution of Global Botulinum Toxin Market (2011)
Percentage Distribution of Global Botulinum Toxin Procedures by Region (2011)
Global Dermal Filler Market (2010-2012)
Percentage Distribution of Total Global HA Dermal Filler Procedures (2011)
Botulinum Toxin Type A Procedures in The US (2009-2012)
Gender-Wise Distribution of Total Botulinum Toxin Type A Procedures in The US (2012)
Gender-Wise Percentage Contribution in Botulinum Toxin Type A Procedures in the US (2012)
Botulinum Toxin Type A Revenue in The US (2010-2012)
HA Filler Procedures in the US (2009-2012)
Gender-Wise Distribution of HA Filler Procedures in the US (2012)
Gender-Wise Percentage Contribution in HA Filler Procedures in the US (2012)
HA Filler Revenue in the US (2010-2012)
Total HA Filler in China (2012-2016E)
Botulinum Filler Revenue in Korea (2006-2012)
Global Botulinum Toxin Market – By Company (2012)
Percentage Distribution of Global Botulinum Toxin Market – By Company (2012)
Global HA Filler Market – By Company (2012)
Percentage Distribution of Global HA Filler – By Company (2012)
China HA Filler Market Share Breakdown (2012)
Penetration Rate of HA Filler Brands in China (Q113)
Korea Botulinum Toxin Market – By Company (2012)
Percentage Distribution of Korea Botulinum Toxin Market – By Company (2012)
Allergan Inc Revenues by Product Line (2012)
Allergan Revenues and Net Income (2008-2012)
Merz Pharma Revenue by Business Segments (2012)
Merz Pharma Revenues and Net Income (2009-2012)
Ipsen Revenue by Business Segments (2012)
Ipsen Revenues and Net Income (2010-2012)

LIST OF TABLES

Top 25 Countries by Percentage of Total Aesthetic Procedures (2011)
Top 25 Countries by Percentage of Total Aesthetic Surgical Procedures (2011)
Aesthetic Surgical Procedures in the US (2011-2012)
Top 25 Countries by Percentage of Total Aesthetic Non-Surgical Procedures (2011)
Aesthetic Non-Surgical Procedures in the US (2011-2012)
Facelifts vs Facial Injectables
Types of Facial Injectables
Botulinum Toxin Applications
Prices of Botulinum Toxin Procedures (2012)
Classification of Dermal Fillers by Originating Material
Classification of Dermal Fillers by Action
Price of Various Dermal Filler Procedures
Botulinum Toxin Competitive Landscape
Comparison of Approved HA Filler Brands in China
Comparison of Botulinum Toxin Products in Korea


More Publications